GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Cyclically Adjusted Price-to-FCF

Decision Diagnostics (Decision Diagnostics) Cyclically Adjusted Price-to-FCF : (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Decision Diagnostics Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Decision Diagnostics's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Cyclically Adjusted Price-to-FCF Chart

Decision Diagnostics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec17 Dec18 Dec19 Dec20
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Decision Diagnostics Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Decision Diagnostics's Cyclically Adjusted Price-to-FCF

For the Pharmaceutical Retailers subindustry, Decision Diagnostics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decision Diagnostics's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Decision Diagnostics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Decision Diagnostics's Cyclically Adjusted Price-to-FCF falls into.



Decision Diagnostics Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Decision Diagnostics's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2021 is calculated as:

For example, Decision Diagnostics's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2021 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2021 (Change)*Current CPI (Sep. 2021)
=-0/115.7343*115.7343
=0.000

Current CPI (Sep. 2021) = 115.7343.

Decision Diagnostics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200703 -0.226 86.640 -0.302
200706 -0.116 87.906 -0.153
200709 0.036 87.964 0.047
200712 -0.434 88.616 -0.567
200803 0.029 90.090 0.037
200806 -0.008 92.320 -0.010
200809 -0.017 92.307 -0.021
200812 -0.185 88.697 -0.241
200903 0.127 89.744 0.164
200906 -0.101 91.003 -0.128
200909 0.102 91.120 0.130
200912 -0.126 91.111 -0.160
201003 0.088 91.821 0.111
201006 -0.024 91.962 -0.030
201009 0.016 92.162 0.020
201012 -0.212 92.474 -0.265
201103 0.017 94.283 0.021
201106 -0.027 95.235 -0.033
201109 -0.056 95.727 -0.068
201112 0.037 95.213 0.045
201203 -0.010 96.783 -0.012
201206 -0.002 96.819 -0.002
201209 0.010 97.633 0.012
201212 -0.003 96.871 -0.004
201303 -0.009 98.209 -0.011
201306 -0.009 98.518 -0.011
201309 -0.088 98.790 -0.103
201712 0.000 104.011 0.000
201812 0.000 105.998 0.000
201903 -0.004 107.251 -0.004
201906 -0.003 108.070 -0.003
201909 0.000 108.329 0.000
201912 -0.001 108.420 -0.001
202003 -0.002 108.902 -0.002
202006 -0.002 108.767 -0.002
202009 -0.002 109.815 -0.002
202012 0.000 109.897 0.000
202103 -0.001 111.754 -0.001
202106 -0.002 114.631 -0.002
202109 0.000 115.734 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Decision Diagnostics  (OTCPK:DECN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Decision Diagnostics Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Decision Diagnostics (Decision Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Executives
Keith Berman director, officer: Secretary 2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich director 765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox director, officer: President

Decision Diagnostics (Decision Diagnostics) Headlines

From GuruFocus